Provided are methods of treating inflammatory disorders, autoimmune disorders, or a hematological malignancies using compounds of formula Iand pharmaceutically acceptable tautomers, salts, or stereoisomers thereof. Such disorders and conditions include leukemia and Non Hodgkin's Lymphoma.